FDA approves Ironwood’s combination gout treatment
August 22, 2017Manufacturing and Production, Sales and Marketing Duzallo, FDA, Ironwood Pharmaceuticals, gout, life sciences, pharma, pharmaceuticals
Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout …
Outcry after private hospitals receive tax breaks instead of NHS
August 22, 2017Manufacturing and Production, Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks …
Taking science and making people feel connected to it
August 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical, rare diseases
Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …
Antibacterial power of mother’s milk revealed
August 21, 2017Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Researchers from Vanderbilt University have discovered a previously unknown ability of a compound in mother’s milk to protect new-borns from …
US Congressmen accuse Teva of price hikes over 1,000%
August 21, 2017Sales and Marketing Copaxone, Teva, life sciences, medicine, multiple sclerosis, pharma, pharmaceutical, price hiking
A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of …
Samsung Bioepis collaborates to make inroads into original drugs
August 21, 2017Research and Development, Sales and Marketing Samsung Bioepis, Takeda, biotech, drugs, pharma, pharmaceutical
Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …
New study debunks hypothesis that antidepressants are ineffective
August 21, 2017Research and Development, Sales and Marketing SSRIs, anti-depressants, citalopram, life sciences, medicine, paroextine, pharma, pharmaceuticals
A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …
Novartis begins ‘next-generation’ malaria treatment trial
August 21, 2017Research and Development, Sales and Marketing MMV, Novartis, biotech, drugs, malaria, pharma, pharmaceutical
Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …
Top Ten most popular articles on Pharmafile.com this week
August 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten
A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …
The pendulum swing of generic drug prices
August 18, 2017Medical Communications biotech, drugs, generics, pharma, pharmaceutical
The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to …
Pfizer’s leukaemia drug gets opposing regulatory decisions on either side of the Atlantic
August 18, 2017Medical Communications, Sales and Marketing Besponsa, Cancer, FDA, NICE, Pfizer, leukaemia, pharma, pharmaceutical
Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval …
AZ and MSD secure three bits of good news on key drug
August 18, 2017Medical Communications, Sales and Marketing AstraZeneca, MSD, biotech, drugs, pharma, pharmaceutical
It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …
Longest-serving chief exec in NHS sacked for ‘gross misconduct’
August 18, 2017Medical Communications NHS, Newcastle, biotech, drugs, pharma, pharmaceutical
Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he …
Where will the next cardiovascular breakthrough come from?
August 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Heart Foundation, cardiovascular disease, heart, heart disease, pharma, pharmaceutical
British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …
Independent research may change the immunotherapy game
August 17, 2017Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical
Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …
FDA recalls liquid pharma products after bacterial contamination detected
August 17, 2017Medical Communications, Sales and Marketing FDA, life sciences, pharma, pharmaceutical
The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products …
Alexion moves to bolster patent protection of Soliris
August 17, 2017Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris
Soliris brought in net sales of $2.8 billion last year for Alexion, meaning it accounted for close to 90% of …
Novo diabetes drug outperforms Lilly rival at Phase 3
August 17, 2017Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes
Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …
Cancer Research UK and NU agree three-year research Astex Pharma deal
August 17, 2017Research and Development, Sales and Marketing Astex pharmaceuticals, Cancer Research UK, Newcastle University, biotech, drugs, pharma, pharmaceutical
Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …
New personalised molecular blood test could shake up cancer treatment
August 16, 2017Research and Development Cancer, life sciences, medicine, pharma, pharmaceutical, standford university
A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
